In a hamster model of cardiomyopathy, administration of the osteopontin-derived (SVVYGLR) SV peptide improved cardiac function and attenuated LV dilatation and cardiomyocyte hypertrophy [186]. The gene discussed is SPP1; the disease is cardiomyopathy.